Research and Innovation
Precision prevention means developing tools to map each person’s individual risk factors for cancer, and creating bold new strategies to reduce those risks.
Newly patented plant virus-based immunotherapy could bring new options for inflammatory breast cancer patients.
Researchers and clinicians synergize basic research with commercial entrepreneurship to open new doors in the field of radiation oncology.
Hear from an expert medical panel about groundbreaking developments happening around precision prevention and cancer care at Dartmouth Cancer Center.
For 50 years, doctors and scientists at Dartmouth Cancer Center have been expanding the boundaries of cancer care, including breakthroughs in immunotherapy, that use the body’s own immune system to combat cancer.
The record-breaking $4M raised by the 40th annual Prouty helps cancer researchers break ground on what will become the latest scientific advancements in cancer.
A new immune-profiling method could support personalized prediction of outcomes in immunotherapy patients.
A biomedical informatics team at Norris Cotton Cancer Center has developed AI for colorectal polyp classification that a recent clinical trial showed is useful to practicing pathologists.
Funds will help to improve care coordination across cancer subspecialties and reduce disparities.
Launched in 2020, the Dartmouth Innovations Accelerator for Cancer is turning research concept into action.